Medicare Enrolled
Dr. Edan Shapiro, MD
Urology Physician · Fayetteville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shapiro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shapiro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shapiro
Dr. Edan Shapiro is an urology physician in Fayetteville, GA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Shapiro performed 3,127 Medicare services across 2,423 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shapiro received a total of $17,378 from 67 pharmaceutical and/or device companies across 745 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shapiro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 27% volume in GA
$17,378 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,127
Medicare services
Top 27% in GA for urology physician
2,423
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~184 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
695 | $2 | $21 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
480 | $61 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
365 | $89 | $233 |
| PSA test (prostate cancer screening) | 245 | $18 | $109 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
125 | $213 | $407 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
116 | $58 | $696 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
106 | $72 | $241 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
102 | $17 | $245 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
101 | $94 | $269 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
99 | $4 | $134 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 84 | $132 | $964 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
80 | $8 | $78 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
63 | $3 | $21 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
62 | $25 | $111 |
| Functional activity therapy A therapy procedure that utilizes functional activities as part of the treatment process. |
60 | $21 | $76 |
| Neuromuscular re-education therapy, per 15 min A therapy procedure designed to re-educate the functional connection between the brain, nerves, and muscles. It is billed in 15-minute increments. |
43 | $18 | $55 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
42 | $44 | $185 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
41 | $27 | $58 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $114 | $350 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
27 | $59 | $244 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
23 | $45 | $206 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $102 | $195 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
20 | $90 | $1,352 |
| Sacral nerve stimulator electrode insertion A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves. |
16 | $312 | $7,312 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
15 | $118 | $500 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $321 | $2,667 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
13 | $23 | $82 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
11 | $116 | $704 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $88 | $606 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
11 | $22 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
5.7% medium
92.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,378
Total received (2018-2024)
Avg $2,483/year across 7 years
Top 11% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
745
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,197 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$180 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,067
2023
$4,998
2022
$2,985
2021
$2,799
2020
$1,045
2019
$1,751
2018
$734
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$997
Axonics, Inc.
$294
Boston Scientific Corporation
$239
Sumitomo Pharma America, Inc.
$188
Teleflex LLC
$184
PFIZER INC.
$134
Bayer Healthcare Pharmaceuticals Inc.
$109
Myriad Genetic Laboratories, Inc.
$99
Janssen Biotech, Inc.
$93
Olympus America Inc.
$76
Tempus AI, Inc
$72
COLOPLAST CORP
$64
ABBVIE INC.
$63
Astellas Pharma US Inc
$61
PROCEPT BioRobotics Corporation
$56
UROGEN PHARMA, INC.
$52
Becton, Dickinson and Company
$44
AngioDynamics, Inc.
$43
AstraZeneca Pharmaceuticals LP
$43
Merck Sharp & Dohme LLC
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Valencia Technologies Corporation
$22
Laborie Medical Technologies Corp.
$18
Ferring Pharmaceuticals Inc.
$18
ACCORD HEALTHCARE, INC.
$16
C. R. Bard, Inc. & Subsidiaries
$16
Verity Pharmaceuticals Inc.
$15
Top 3 companies account for 49.9% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$3,150
Boston Scientific Corporation
$1,765
Astellas Pharma US Inc
$1,620
Teleflex LLC
$1,530
BOSTON SCIENTIFIC CORPORATION
$917
Janssen Biotech, Inc.
$695
PFIZER INC.
$613
Valencia Technologies Corporation
$607
NeoTract Inc.
$479
Endo Pharmaceuticals Inc.
$439
PROCEPT BioRobotics Corporation
$428
Axonics, Inc.
$381
AstraZeneca Pharmaceuticals LP
$334
Medtronic USA, Inc.
$307
Coloplast Corp
$285
Sumitomo Pharma America, Inc.
$259
Merck Sharp & Dohme Corporation
$223
Bayer HealthCare Pharmaceuticals Inc.
$193
Kowa Pharmaceuticals America, Inc.
$188
Bayer Healthcare Pharmaceuticals Inc.
$182
Dendreon Pharmaceuticals LLC
$176
SRS Medical Systems, Inc.
$154
Amgen Inc.
$148
Myriad Genetic Laboratories, Inc.
$137
AbbVie Inc.
$126
Blue Earth Diagnostics Limited
$124
Olympus America Inc.
$121
Myovant Sciences Inc.
$116
ABBVIE INC.
$98
Merck Sharp & Dohme LLC
$92
AngioDynamics, Inc.
$88
Ferring Pharmaceuticals Inc.
$87
C. R. Bard, Inc. & Subsidiaries
$84
Laborie Medical Technologies Corp.
$82
COLOPLAST CORP
$79
Tempus AI, Inc
$72
UROGEN PHARMA, INC.
$67
Allergan, Inc.
$63
Becton, Dickinson and Company
$62
UROVANT SCIENCES INC
$60
Clarus Therapeutics Inc.
$60
Sun Pharmaceutical Industries Inc.
$56
Photocure Inc
$52
Aytu BioScience, Inc
$48
Palette Life Sciences, Inc.
$43
Avadel Specialty Pharmaceuticals, LLC
$41
AbbVie, Inc.
$41
Axonics Modulation Technologies, Inc.
$41
Stryker Corporation
$38
Ethicon US, LLC
$35
ABC Home Medical Supply, Inc.
$30
UroGen Pharma, Inc.
$28
180 Medical, Inc.
$26
PALETTE LIFE SCIENCES, INC.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
ConvaTec Inc.
$19
Progenics Pharmaceuticals, Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
ACCORD HEALTHCARE, INC.
$16
BAXTER HEALTHCARE
$16
Verity Pharmaceuticals Inc.
$15
Covidien LP
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
E.R. Squibb & Sons, L.L.C.
$13
Janssen Pharmaceuticals, Inc
$12
Travere Therapeutics, Inc.
$6
Retrophin, Inc.
$4
Top 3 companies account for 37.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 1588 · ADSTILADRIN · AMS 700 CXR RTE Kit · AMS 800 Artificial Urinary Sphincter · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard TigerTail Flexible Tip Ureteral Catheters · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CERTUS 140 MICROWAVE ABLATION SYSTEM · CYSVIEW · Certus 140 · Cysview · ERLEADA · EVENITY · Erleada · FIRMAGON · FLOSEAL · GEMTESA · GENERAL BPH · GENERAL THERAPIES · GENERAL THERAPIES · GENERAL - BPH · GENERAL - ERECTILE DYSFUNCTION · GENERAL BPH · GENTLECATH GLIDE · General - BPH · General - Therapies · INTERSTIM · INTERSTIM ICON · Isiris aStent Removal Device · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LigaSure · LithoVue · Lumenis Pulse 120H · Lynx System · MYRBETRIQ · Myrbetriq · NANOKNIFE · Natesto · Noctiva · Non-Covered · Nubeqa · OBTRYX · OPDIVO · ORGOVYX · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · PENILE & TESTICULAR RECONSTRUCTN · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolia · REZUM · Rezum Generator · SEGLENTIS · SKYLITE · SPACEOAR · SPACEOAR VUE · SPEEDICATH · SWISS LITHOCLAST TRILOGY · Seglentis · Solyx SIS System · SpaceOAR System · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · TOVIAZ · TRIA · Thiola · Titan · Trelstar · UROLIFT · Upsylon · UroCuff · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · eCoin Device Kit · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
74
Per 100K population
61.3
County median income
$108,986
Nearest hospital
PIEDMONT FAYETTE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shapiro is a clinical cardiology specialist, with above-average Medicare volume (top 27% in GA), with low-engagement industry engagement in the top 11% of GA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shapiro experienced with automated urinalysis?
Based on Medicare claims data, Dr. Shapiro performed 695 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shapiro receive payments from pharmaceutical companies?
Yes. Dr. Shapiro received a total of $17,378 from 67 companies across 745 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shapiro's costs compare to other urology physicians in Fayetteville?
Dr. Shapiro's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shapiro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fayetteville
Browse urology physicians in Fayetteville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology